Company Overview - PROCEPT BioRobotics Corporation (PRCT) currently holds a Momentum Style Score of A, indicating strong momentum potential [3] - The company has a Zacks Rank of 2 (Buy), suggesting favorable market performance [4] Price Performance - PRCT shares have increased by 34.2% over the past week, while the Zacks Medical - Instruments industry remained flat during the same period [6] - Over the past month, PRCT's price change is 32.49%, significantly outperforming the industry's 2.19% [6] - In the last quarter, PRCT shares rose by 52.15%, and over the past year, they gained 198.93%, compared to the S&P 500's increases of 13.52% and 37.4%, respectively [7] Trading Volume - The average 20-day trading volume for PRCT is 1,193,537 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the past two months, 6 earnings estimates for PRCT have been revised upwards, while none have been revised downwards, leading to an increase in the consensus estimate from -1.74 [10] - For the next fiscal year, 5 estimates have moved upwards, with 1 downward revision during the same period [10]
Are You Looking for a Top Momentum Pick? Why PROCEPT BioRobotics Corporation (PRCT) is a Great Choice